Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

Published:2024-11 Issue: Volume:277 Page:145-158
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Jain Sneha S.,Mahaffey Kenneth W.,Pieper Karen S.,Shimizu Wataru,Potpara Tatjana,Ruff Christian T.,Kamel Hooman,Lewis Basil S.,Cornel Jan H.,Kowey Peter R.,Horrow Jay,Strony John,Plotnikov Alexei N.,Li Danshi,Weng Stephen,Donahue Julia,Gibson C. Michael,Steg P. Gabriel,Mehran Roxana,Weitz Jeffrey I.,Johnston S. Claiborne,Hankey Graeme J.,Harrington Robert A.,Lam Carolyn S.P.^ORCID

Funder

Bristol-Myers Squibb

Janssen Research & Development LLC

Publisher

Elsevier BV

Reference56 articles.

1. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Joglar;Circulation,2024

2. Heart disease and stroke statistics-2023 update: a report from the American heart association;Tsao;Circulation,2023

3. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010;Chugh;Study. Circulation.,2014

4. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019;Dong;Europace,2023

5. Atrial fibrillation as an independent risk factor for stroke: the Framingham study;Wolf;Stroke,1991

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP